MEDTOX Journal. In This Issue. Public Safety Substance Abuse Newsletter August 2010
|
|
- Rosaline Jefferson
- 8 years ago
- Views:
Transcription
1 MEDTOX Journal Public Safety Substance Abuse Newsletter August 2010 In This Issue Trends in Adolescent Drug Abuse: "Starter Heroin and the Smell of Cheese Non-medical Use of Opiates and Benzodiazepines Continue to Climb Junior High and High School Campus-Based Drug Testing Programs From the Hotline: Phenibut Update Thank you for reading the MEDTOX Journal. We hope that you find it interesting and informative. Please join our mailing list to receive the MEDTOX Journal monthly, at no charge. If you have questions or suggestions on articles you would like to see featured, please contact us at For a PDF Version of the newsletter click here: PDF Version of Newsletter. Buprenorphine and HIV Treatment
2 Name That Drug Trends in Adolescent Drug Abuse: "Starter Heroin" and the Smell of Cheese Non-medical Use of Opiates and Benzodiazepines Continue to Climb Prescription opiates (hydrocodone, oxycodone, codeine) and benzodiazepines (diazepam, alprazolam and lorazepam) have become some of the most popularly abused prescription drugs in America. A spate of celebrity overdoses and deaths has spotlighted this problem. Non-medical utilization of these drugs and the subsequent overdoses exceeds the carnage of fatal automobile accidents in some states, especially in adult populations ages Prescription opiate abuse is dominated by Calls to the DAR Hotline have increased in recent weeks in response to unusual changes in adolescent drug abuse. In particular, callers from Texas and Arizona have inquired about a drug called "cheese" or "mickey juice." This drug is a substance that we first reported on two years ago when it was alleged to be the cause of scores of overdoses and deaths in the Dallas- Ft. Worth area. Scroll forward to the present and we find that this form of "starter heroin" continues to plague communities in the southwest. It appears that Texas still bears the brunt of "cheese." Reports of its use in hydrocodone and oxycodone; the most common forms of these drugs are Vicodin and Oxycontin. Diazepam (valium) is a member of a separate classification of drugs called benzodiazepines. Included in this family of substances are Ativan (lorazepam) and Xanax (alprazolam). The benzodiazepines are frontline medications used to induce sleep and reduce anxiety. Frequently both classes of prescription drugs are combined to form "loads." The composition of "loads" varies from city to city and region to region. More often than not, alcohol is mixed with these prescription drugs. When this occurs, a pharmacological synergy ensues resulting in exaggeration of sedative symptoms and physiological loss of control. A trip to the emergency room often follows. The Drug Abuse Warning Network (DAWN) researchers evaluated a sampling of emergency room records from 231 hospitals. From 2004 to 2008, emergency room visits for nonmedical use of opiates increased from 140,000 to 300,000, a 111% increase over that period. The reason most cited for the emergency room visits was concern for patient overintoxication and/or overdose from use of oxycodone, hydrocodone, and/or methadone prescription drugs. The benzodiazepines experienced an 89% caused increase in ER visits as well over the same period of time. ER visitation rates peaked among people ages 21 to 24; nearly one quarter of those who visited the hospital were ultimately admitted. Not
3 other states have been sporadic. The impact of this problem is borne by young, oftentimes inexperienced drug using teenagers. The drug is priced squarely for use by young drug users; its purity is relatively low and led to the drug's designation as "starter heroin." "Cheese" is a compound made up of black tar heroin and Tylenol PM. Black tar is a potent, less refined form of heroin. It's typically found as a sticky and very black goo. The drug can be smoked or it can be injected intravenously. "Cheese" purveyors mix water, crushed Tylenol PM, and black tar heroin together. The mixture is then heated mildly to evaporate off the water and to create a crispy powdery appearance. The final dried product has the appearance of parmesan cheese, hence its name. The drug is packaged in ¼ to ½ gram bindles in wax or notebook paper. A bindle of "cheese" can cost anywhere from $5 to $10. Purity of "cheese" can range from 5%- 20%, substantially less than that of tar heroin alone. The drug is typically snorted, but there have been seizures of "cheese" crammed into gelatin capsules. captured in this data is the role that adjunct non-medical drug use plays in ER visits. Carisoprodol (Soma) and Zolpidem (Ambien) are popularly abused drugs that possess powerful sedative features. Soma in particular is a widely abused drug, one whose popularity goes well beyond its putative value as a muscle relaxant. This barbiturate-like drug is mixed with prescription opiates (Vicodin or Percocet) to create one of the most popular "loads" for America drug abusers. This dangerous and addictive phenomenon is poorly appreciated and infrequently monitored by judicial and medical professionals. Non-medical use of prescription drugs continues to climb. In 2008, the number of ER visits involving non-medical use of prescription drugs equaled the number of visits for illicit drugs (methamphetamine, cocaine, ecstasy, and GHB). Physicians assigned to emergency rooms, occupational medicine centers and other clinical settings should be sensitive to this development. Family physicians should also be vigilant for signs of non-medical prescription drug use in their practices. Urine drug testing is an effective means of monitoring this problem. In a recent publication of the American Family Physician [1], family doctors were encouraged to undertake regular, broad-spectrum urine drug screening for the purpose of detecting of both licit and illicit drugs. In the journal, urinalysis was touted as a valuable office procedure for physicians and other healthcare providers. [1] Standridge JB, Adams SM, Zotos AP. Am Fam Physician Mar 1;81 (5): Junior High and High School Campus-Based Drug Testing Programs Fire Up for the Fall Semester Almost half of all people in grade 12 have used illicit drugs at one point or another[1]. Many parents and school administrators are concerned with the effect that drugs and alcohol are having on students in terms of academic performance, dropout rates and disruptive behavior. One
4 As is the case with use of any opiate, chronic or frequent use of this drug will provoke addiction and dependency. Even though the purity of "cheese" is significantly less than other forms of heroin, it can quickly and easily overcome an adolescent user. The depressant effects of heroin in "cheese" are exacerbated by the additive effects of diphenhydramine; the antihistamine constituent of Tylenol PM. Diphenhydramine is the principle ingredient of Benadryl, a medication that is widely utilized as a sleep aid. When combined with the heroin in "cheese," users experience a profound sense of relaxation and calm. Non-tolerant users of "cheese" will display classic symptoms of opiate abuse: lethargy, somnolence, droopy eyelids, constricted pupils, dry mouth and slow speech. Because of the depressant effects of diphenydramine, "cheese" users will also display evidence of nystagmus and nonconvergence. Concentrated doses of diphenhydramine can cause frank hallucinations and a catatonic like affect. The more direct effects of this form of heroin will last for 3-6 hours. Signs of withdrawal from increasingly popular solution to these problems is voluntary school-based drug testing. What exactly is voluntary schoolbased drug testing? In collaboration with a number of large and small school districts, MEDTOX has created a highly affordable drug-testing program that has excited parents, school officials, and yes, the students themselves. This system is an all-encompassing program that is comprised of three interlocking sections: parent and student education, randomly sampled drug testing, and professional counseling and rehabilitation (if required). The program provides participating schools with educational seminars that are taught by some of America's most respected substance abuse experts. These free and frequent seminars empower parents and students by providing them with real life, no nonsense factual discussions about the dangers of alcohol and drugs. Program lecturers provide insight for parents into the Internet world where drugs sales are arranged and cabinet parties are scheduled. This experience is shocking for many of the parents who attend. You can hear a pin drop in the lecture halls when parents hear about how Facebook and social networking sites are exploited by students to organize and coordinate parties and other meetings where drugs and alcohol are used. In the end, students and parents find themselves on the same page in understanding the nature and the extent of their local drug scene. Seminar leaders provide tudents and parents with strategies for dealing with the various forces that tug at students to use drugs and alcohol. This school-based drug-testing program that is available for students in grades 7 through 12 is completely confidential and private. It is firewalled so that testing results are kept discreet; they're not shared with school officials. Positive test results are communicated to parents through the auspices of a medical review officer (MRO). Test results are treated as a private health care matter. These programs are completely voluntary with opt in forms necessary for each parent and student to sign and acknowledge. Either student or parent can verbally opt out of the program at any time. Once a student is enrolled in the program, he/she is then assigned to a pool that is subjected to random selection and collection. Professionally trained collectors operate at participating schools at discrete, out-of-the-way locations on the school grounds; collectors have access to a variety of onsite urine and oral fluid screening devices. Presumptive positive samples are sent to a lab overnight. Once a sample has been produced by a participating student, he/she is free to return to class. It takes a student less than 15 minutes. Positive screening results are confirmed at the SAMHSA certified laboratory utilizing gas chromatography/mass spectrometry (GC/MS) technology.
5 "cheese" are likely to be noticeable within 8-12 hours of the cessation of direct effects. Peak withdrawal symptoms will occur between hours following last dose. At present, "cheese" is mostly a regional phenomenon of Texas. Isolated seizures of "cheese" in other border states have not been significant. Mexico is the source of nearly all tar heroin consumed in the United States. Texas's proximity to Mexico puts it in the crosshairs of smugglers and cartel operations. With Nuevo Laredo (MX) becoming a focus point of cartel controlled tar heroin smuggling, communities proximate to the border are likely to see continued abuse of "cheese." Parents, teachers and friends should be sensitive to sudden and inexplicable behavioral changes in adolescents. Poor performance in school, withdrawal from friends and from hobbies and an affect of exhaustion are all suggestive of a "cheese" abuse problem. Treatment of "cheese" addiction and dependency may require in-patient detoxification and enrollment in an intensive outpatient program afterwards. Early intervention in a student's inclination to use drugs and/ or alcohol has proven critical in deterring substance abuse problems later in life. Random drug testing programs also provide students with motivations and social "cover" in handling peer pressure directed at them to use drugs at parties and at other gatherings. Reducing the rates of student drug testing can save lives as well. With prescription drugs topping the list of junior high school and high school drug abuse tendencies these days, a random testing program is a means of slowing or even reversing the pace of abuse for substances such as Vicodin, Oxycontin and Percocet. Depending on the nature of a local drug problem, a schoolbased program may also screen for abuse of over-the-counter drugs and botanical hallucinogens, substances that are exceedingly popular with high school students. The programs are easy to customize and fit to the on-the-ground realities affecting a participating school or school district. These programs are endorsed by the California Narcotic Officer's Association (CNOA), the Coalition for a Drug Free California and the Partnership for Responsible Parenting. If you want more information about this new program, please contact a MEDTOX sales representative or a Drug Abuse Recognition (DAR) Program representative at medtoxjournal@medtox.com. [1] From the Hotline: Phenibut Update We've previously reported on widespread use of a noncontrolled sedative called Phenibut. The drug has been sold and traded on the Internet below the radar of law enforcement and regulatory authorities. Up to now, most U.S. phenibut has been sourced from the U.K. and Europe. But recently, an "over-the-counter" Internet marketed product containing phenibut has surfaced in America. Called "Tranquila PM," this compound contains 350 mg of 4-amino, 3-phenylbutyric acid (Phenibut) and an array of vitamins and herbs. The product is packed into a small 2 fl. oz., oneshot plastic bottle that's designed for fast, nohassle ingestion. Tranquila PM's marketing
6 MEDTOX Quick Links Our Website Products Services Contact Us Past Issues message states that the drug is a worthy alternative to traditional prescriptions and overthe-counter sleep aids. One online purveyor of Tranquila PM asserts that a single dose of the drug brings about a "general relaxation effect that leads to a sound and restful sleep." ( Phenibut is a chemical relative of the inhibitory amino acid transmitter, GABA. The drug possesses some of the sedative powers of gabapentin (Neurontin), Baclofen and gamma hydroxy butyrate (GHB). Its effects are mediated through its agonist actions at GABAB receptors; the drug exerts less of an effect at GABAA receptors. In some Internet drug cafes, phenibut is advocated as a means of weaning off of powerful drugs such as GHB and GBL. It's also advocated for those that want to avoid the withdrawals from other depressant drugs, such as alcohol and benzodiazepines. The drug is also alleged to be an aphrodisiac. In its early development stages, the drug was also thought to be nootropic (a memory enhancer). In fact, modern phenibut aficionados tout it as a "smart drug," something akin to the prescription drug Provigil and several other substances thought to be cognitive accelerants. The Russian space program even packed phenibut into the medicine chests of the Soyuz spacecraft. Phenibut is not known to cross-react or otherwise interfere with modern drug test systems. Someone who uses phenibut products will not yield a positive drug test for a controlled substance. But phenibut does pose challenges to readers who work in the drug rehabilitation industry. For patients in recovery, phenibut poses risks. In particular, patients with alcohol and central nervous system depressant addictions may get undesirable drug cravings from the sedating and euphoric effects of phenibut. For others working in residential programs and sober living homes, phenibut use by participants could threaten the safety and security of the house. Chronic phenibut use can lead to tolerance. There have been reports of withdrawal following extended periods of use. Tranquila PM contains a warning to users that following two weeks of continuous use of the drug, a 5-7 day drug holiday should be taken. That admonishment from a phenibut distributor sums up the dangers that a drug like phenibut poses to people in recovery and the people and programs that support them.
7 Buprenorphine and HIV Treatment In communities where intravenous use of drugs is rampant, so is HIV. When people with HIV are also addicted to opiates, treating both simultaneously helps improve outcomes and reduces the spread of HIV or other infections that are transmitted through needle sharing and/or risky sexual behaviors. Combining and coordinating care for the HIV-opiate addicted patient has been spotty. Treatment systems typically fail to integrate the care of one condition in coordination of the other. Patients with HIV and opiate dependencies have traditionally been unable to get coordinated treatment for their conditions in one clinical setting. With expansion of buprenorphine treatment into clinics staffed by HIV clinicians, patients now have the option of receiving treatment of both opioid addiction and HIV infection contemporaneously. With this development, a growing body of evidence suggests that patients and the state of public health will benefit. Since 2002, buprenorphine has been available in the U.S. as an office-based treatment for opioid dependency. This development represented a substantial realignment of drug treatment resources from the inpatient clinic environment to smaller outpatient offices where individual or small groups of physicians organize and manage drug treatment. Physicians who want to prescribe buprenorphine must undergo a training program and become certified by the Substance Abuse and Mental Health Services Administration (SAMHSA). Buprenorphine has been a game-changing drug because of its ability to expand access to treatment for opiate addicts. Nearly 19,000 physicians are currently certified to prescribe buprenorphine; most are medical doctors and osteopathic physicians working general practices and family medicine. Studies suggest that patients with HIV infection and untreated opiate addictions often experience delayed treatment until the later phases of the disease. Delays in treatment of HIV result in extended period of risky behavior and I.V. drug use that puts them and their partners at risk for new infections. Treating affected patients for both HIV and opiate dependency can improve their outcomes on both counts. New research suggests that buprenorphine has several advantages over traditional methadone maintenance programs. A recent randomized trial found that office-based care can improve addiction related outcomes for patients with HIV and opioid dependency and may lead to more effective interventions. [1] The results of the trial indicated that patients randomized to
8 clinic-based buprenorphine therapy entered addiction treatment much more quickly than those who were assigned to specialty addiction treatment centers elsewhere. Retention in the clinic-based treatment programs was much better than it was in the more distant treatment centers. Patients receiving buprenorphine in the clinic environment also had fewer urine test results that were positives for other opiates or cocaine. These patients also visited their primary HIV physicians more frequently. These are all positive outcomes effecting treatment success rates. It may also be the case that buprenorphine has fewer interactions with antiretroviral drugs than methadone. Methadone is the more traditional opiate agonist used in narcotic replacement therapy regimens. Studies suggest that an antiretroviral can trigger withdrawals in some patients taking methadone; this does not seem to happen when buprenorphine is used. Trying to get HIV patients to abide by their treatment plans and take antiretroviral drugs is difficult when they're experiencing the gnawing pangs and pains of opiate withdrawal. Buprenorphine may well enhance compliance with HIV treatment regimens. As a mixed property narcotic analgesic, buprenorphine is less sedating than methadone and poses fewer side effects and interactions with HIV treatment. Buprenorphine is a drug that can be used in a variety of different settings to treat stubborn opioid addiction. With greater expansion of buprenorphine-trained physicians into community clinical settings, HIV patients and others with complicated medical histories may experience better healthcare outcomes and a more satisfying quality of life. [1] Lucas GM et al. Annals of Internal Medicine 2010, Clinic-Based Treatment of Opioid-Dependent HIV-Infected Patients Versus Referral to an Opioid Treatment Program. 2010; 152:
9 Name That Drug The subject of this month's "name that drug" is a substance of significant complexity and great potential. A relative newcomer to the mean streets of drug abuse, this substance has established itself as one of the most after prescription drugs in the world for reasons that you might not expect. This month's drug came into the pharmaceutical world as (2S)-2-[(-)-(5R,6R,7R,14S)-9α- cyclopropylmethyl-4,5-epoxy-6,14-ethano- 3-hydroxy-6-methoxymorphinan-7-yl]-3,3- dimethylbutan-2-ol. Embedded in the International Union of Pure and Applied Chemistry (IUPAC) nomenclature is a hard clue as to this drug's biochemical makeup. The drug is an opiate, a distillate of the minor opium constituent called Thebaine. This month's drug is one of a half-dozen notable Thebaine derivatives that includes oxymorphone (Opana), oxycodone (Oxycontin) and naloxone (Narcan). The drug is a semi-synthetic opioid controlled in the United States under terms of DEA Schedule III. This drug resembles the chemical actions and mixed characteristics of pentazocine (Talwin), the subject of July's newsletter "name that drug" column. The drug is available by prescription in several different forms and iterations. In addition to a transdermal patch application, the drug can be found in sublingual and tablet forms. There is a formulation for intramuscular injection and an even newer application that involves an implantable depot format designed for slow, even absorption into the bloodstream. Like Talwin, the drug has been compounded with naloxone to reduce the potential of intravenous injection and parenteral addiction. As a Schedule III medication, the potential for abuse of this drug is rather modest, viewed similarly to drugs like hydrocodone and the opiate cough syrups. In its early years as a prescription medication, the drug was assigned to the much less confining spaces of federal Schedule V. Recent reports and studies of this drug suggest that abuse of it is becoming widespread. This drug is a game changer however. Initially conjured as an opiate analgesic, the drug has since morphed into a powerful means for treating opiate dependency. It has transformed the way opiate addicted patients are now treated and managed. It is foreseeable that this drug may ultimately dispatch more traditional methods of treatment (methadone maintenance).
10 The drug is one of the most powerful opiates in the modern pharmaceutical armamentarium. It possesses affinity for opiate receptors that bests all other modern narcotics, a broad class of medications that includes other powerful drugs such as morphine, fentanyl, methadone and heroin. But what sets this drug apart from other drugs of the opiate class is the binding strength that it demonstrates at opiate receptor sites in the brain. The drug is classified as a mixed property narcotic, and although it possesses unparalleled affinity for opiate receptor sites, it performs as an agonist at some and an antagonist at others. These characteristics make the drug complicated to deal with. Physicians who prescribe the drug must undergo specialized training and certification before they can begin treating patients. This is the only drug of its type where specialized medical instruction is required before utilization. Because of the drug's mixed properties at opiate receptors, someone under the influence of the drug will not experience a traditional opiate euphoria. In fact, some users of the drug describe the effects of this drug as more of an edgy dysphoria. Because of its exclusive action at opiate receptors, the drug can effectively reverse the effects of other opiates that may be present in the bloodstream; this drug competitively preempts other narcotics from opiate receptors in the brain. This effect can be dramatic. For instance, someone who is abusing and is physically dependent on heroin would be put into instant opiate withdrawal if this month's drug were taken. The drug would act similarly and interrupt the action of any other opiate were it to be inadvertently mixed in to a patient or addict's narcotic regimen. Because of this drug's unique chemistry, it acts in blockade at opiate receptor sites, making it important in the practice of drug treatment and rehabilitation. For nearly two generations, methadone has been the go-to therapy in the treatment and management of opiate dependency. Addicted patients who failed in therapy or those who experienced multiple relapses, methadone (dolophine) represented a fairly safe and reliable means of managing the problem. "Methadone maintenance" has been the standard of care therapy in treatment of patients with chronic opiate abuse histories. Methadone substitution therapy crafted a pharmacological solution whereby opiate addicts could pull back from their lives on the street, pull the needles from their arms and transition to a medically supervised therapy that provided them with the necessary narcotics to stave off withdrawals. But in the end, methadone is one of a slew of very potent narcotic analgesics itself, not all that different than the abused opiates it replaces. Methadone is frequently abused too, sometimes fatally. Heroin addicts "chip" and add bits and pieces of other narcotics on top of
11 their methadone therapy to get high. Some methadone patients take to the abuse of drugs like Xanax to create a super methadone cocktail that is uniquely stupefying. This month's mystery drug may dislodge methadone from its primacy in narcotic replacement therapy and become the standard of care for the treatment of narcotic addicts. When utilized in the roll of narcotic replacement therapy, this month's drug can be tricky to use. Physicians have to follow a strict set of protocols to bridge heroin and methadone addicts over to short acting narcotics, such as morphine, before the substitution therapy with this drug can begin. In fact, an addicted patient must actually descend into a mildly acute withdrawal before therapy can begin. Once those withdrawals are evident, the drug is administered. Withdrawals stop shortly afterwards. The dose is adjusted over the course of several days of trial and error. Once sufficient concentrations of the drug are present to suppress withdrawals and a patient has become stable, he/she can then be titrated down off the drug. Becoming more vogue however is the utilization of the drug in the roll of substitution therapy. As is the case with methadone maintenance, affected patients are weaned down to as small a dose as possible and then maintained on a low dose of it over and extended period of time. As an analgesic, this month's drug does not hold a great deal of promise. Its mixed property status makes it a poor candidate to treat most types of moderate and serious pain. But there are some patients where the drug may be an appropriate fit. To that end, physicians have options that include the transdermal patch, a product not to be confused with a fentanyl transdermal patch. As a drug of abuse, there have been sporadic reports of "outbreaks" in communities where the drug is commonly used in treating narcotic dependency. In the club scene, the drug has been found in the possession of those who tend to use ecstasy, GHB and hallucinogens. Many people who use the drug to get high are often disappointed with their purchase. The mixed agonistantagonist properties of this drug often cause it to be a dud on the party scene. And although this drug may come off a little flat for those looking to get high, its real value is in the stabilization, detoxification and maintenance of the addicted opiate patient. For the narcotic dependent and the addicted, this month's drug may be nothing short of a miracle. August 2010 Mystery Drug: Buprenorphine (Suboxone, Subutex, Buprenex)
12 Forward Marketing by This was sent to by Update Profile/ Address Instant removal with SafeUnsubscribe Privacy Policy. MEDTOX Scientific, Inc. 402 West County Road D St. Paul MN 55112
ARCHIVED BULLETIN. Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E
BULLETIN INTELLIGENCE Product No. 2004-L0424-013 SEPTEMBER 2004 U. S. D E P A R T M E N T O F J U S T I C E NDIC Within the past 2 years buprenorphine a Schedule III drug has been made available for use
More information8/1/2014. Who We Are. BHG s Medical Mission. BHG Company Overview
Who We Are BHG s Medical Mission BHG Company Overview Behavioral Health Group (BHG) is a leading provider of opioid addiction treatment services. Our treatment centers provide pharmacotherapeutic maintenance
More informationInformation for Pharmacists
Page 43 by 42 CFR part 2. A general authorization for the release of medical or other information is NOT sufficient for this purpose. Information for Pharmacists SUBOXONE (buprenorphine HCl/naloxone HCl
More informationBuprenorphine/Naloxone Maintenance Treatment for Opioid Dependence
Buprenorphine/Naloxone Maintenance Treatment for Opioid Dependence Information for Family Members Family members of patients who have been prescribed buprenorphine/naloxone for treatment of opioid addiction
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationOpioid/Opiate Dependent Pregnant Women
Opioid/Opiate Dependent Pregnant Women The epidemic, safety, stigma, and how to help. Presented by Lisa Ramirez MA,LCDC & Kerby Stewart MD The prescription painkiller epidemic is killing more women than
More informationThe ABCs of Medication Assisted Treatment
The ABCs of Medication Assisted Treatment J E F F R E Y Q U A M M E, E X E C U T I V E D I R E C T O R C O N N E C T I C U T C E R T I F I C A T I O N B O A R D The ABCs of Medication Assisted Treatment
More informationPRESCRIPTION PAINKILLER OVERDOSES
IMPACT{ POLICY PRESCRIPTION PAINKILLER OVERDOSES National Center for Injury Prevention and Control Division of Unintentional Injury Prevention What s the Issue? In a period of nine months, a tiny Kentucky
More informationConsiderations in Medication Assisted Treatment of Opiate Dependence. Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT
Considerations in Medication Assisted Treatment of Opiate Dependence Stephen A. Wyatt, D.O. Dept. of Psychiatry Middlesex Hospital Middletown, CT Disclosures Speaker Panels- None Grant recipient - SAMHSA
More informationHeroin. How Is Heroin Abused? How Does Heroin Affect the Brain? What Other Adverse Effects Does Heroin Have on Health?
Heroin Heroin is an opiate drug that is synthesized from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears as a white or brown
More informationLike cocaine, heroin is a drug that is illegal in some areas of the world. Heroin is highly addictive.
Heroin Introduction Heroin is a powerful drug that affects the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants to.
More informationopiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 Ranked #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380
opiates alcohol 27 opiates and alcohol 30 April 2016 drug addiction signs 42 ed #1 123 Drug Rehab Centers in New Jersey 100 Top 10 380 effects of alcohol in the brain 100 Top 30 698 heroin addiction 100
More informationHeroin Addiction. Kim A. Drury RN, MSN
Heroin Addiction Kim A. Drury RN, MSN Heroin use is on the rise in our area. Nearly every day the news media reports situations involving Heroin. According to the Substance Abuse and Mental Health Services
More informationUpdate on Buprenorphine: Induction and Ongoing Care
Update on Buprenorphine: Induction and Ongoing Care Elizabeth F. Howell, M.D., DFAPA, FASAM Department of Psychiatry, University of Utah School of Medicine North Carolina Addiction Medicine Conference
More informationHeroin. How is Heroin Abused? What Other Adverse Effects Does Heroin Have on Health? How Does Heroin Affect the Brain?
Heroin Heroin is a synthetic opiate drug that is highly addictive. It is made from morphine, a naturally occurring substance extracted from the seed pod of the Asian opium poppy plant. Heroin usually appears
More informationOpioid overdose can occur when a patient misunderstands the directions
Facts About Opioid Overdose How Does an Overdose Occur? Opioid overdose can occur when a patient misunderstands the directions for use, accidentally takes an extra dose, or deliberately misuses a prescription
More informationPresentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas
Presentation to Senate Health and Human Services Committee: Prescription Drug Abuse in Texas David Lakey, MD Commissioner, Department of State Health Services Lauren Lacefield Lewis Assistant Commissioner,
More informationPrior Authorization Guideline
Prior Authorization Guideline Guideline: CSD - Suboxone Therapeutic Class: Central Nervous System Agents Therapeutic Sub-Class: Analgesics and Antipyretics (Opiate Partial Agonists) Client: County of San
More informationHow To Treat Anorexic Addiction With Medication Assisted Treatment
Medication Assisted Treatment for Opioid Addiction Tanya Hiser, MS, LPC Premier Care of Wisconsin, LLC October 21, 2015 How Did We Get Here? Civil War veterans and women 19th Century physicians cautious
More informationDowners/Depressants (pages 40-50)
Downers/Depressants (pages 40-50) Read pages 49-54, 59-60, and 78-79 of the booklet, Street Drugs. Pages 40-50 of the text. Narcotics: Prescription Origin: Southeast Asia, Southwest Asia, and in the Western
More informationA prisoners guide to buprenorphine
A prisoners guide to buprenorphine 2 The Opium poppy In the land of far, far away the opium poppy grows. The seed pods of this poppy are scratched until they drip with a sticky resin called opium. Raw
More informationOpiate Abuse and Mental Illness
visited on Page 1 of 5 LEARN MORE (HTTP://WWW.NAMI.ORG/LEARN-MORE) FIND SUPPORT (HTTP://WWW.NAMI.ORG/FIND-SUPPORT) GET INVOLVED (HTTP://WWW.NAMI.ORG/GET-INVOLVED) DONATE (HTTPS://NAMI360.NAMI.ORG/EWEB/DYNAMICPAGE.ASPX?
More informationFrequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction
Frequently Asked Questions (FAQ s): Medication-Assisted Treatment for Opiate Addiction March 3, 2008 By: David Rinaldo, Ph.D., Managing Partner, The Avisa Group In this FAQ What medications are currently
More informationTestimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013
Testimony Engrossed House Bill 1101 Department of Human Services Senate Human Services Committee Senator Judy Lee, Chairman February 19, 2013 Chairman Lee, members of the Senate Human Services Committee,
More informationDependence and Addiction. Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania
Dependence and Addiction Marek C. Chawarski, Ph.D. Yale University David Metzger, Ph.D. University of Pennsylvania Overview Heroin and other opiates The disease of heroin addiction or dependence Effective
More informationBeyond SBIRT: Integrating Addiction Medicine into Primary Care
Beyond SBIRT: Integrating Addiction Medicine into Primary Care Community Clinic Association of Los Angeles County 14 th Annual Health Care Symposium March 6, 2015 Keith Heinzerling MD, Karen Lamp MD; Allison
More informationINFORMATION BRIEF. Overview. Prescription Drug Abuse Among Young People
Product No. 2002-L0424-004 INFORMATION BRIEF AUGUST 2002 U. S. D E P A R T M E N T O F J U S T I C E NDIC and Stockbyte Overview Prescription drugs, a category of psychotherapeutics that comprises prescription-type
More informationOpiates Heroin/Prescription Steve Hanson Opiates Dates to 4,000 BC Mimics endorphin activity Natural - Opium, morphine, codeine Semi-synthetic- Heroin, Dilaudid Synthetics - Darvon, Demerol, Fentanyl Modern
More informationST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;03/13;06/14;07/15
ST. CLAIR COUNTY COMMUNITY MENTAL HEALTH Date Issued: 07/09 Date Revised: 09/11;/13;06/14;07/15 WRITTEN BY Jim Johnson Page 1 REVISED BY AUTHORIZED BY Jessica Moeller Debra Johnson I. APPLICATION: THUMB
More informationPractice Protocol. Buprenorphine Guidance Protocol
Practice Protocol Buprenorphine Guidance Protocol Developed by the Arizona Department of Health Services Division of Behavioral Health Services Effective Date: 02/23/11 Title Buprenorphine Guidance Protocol
More informationA G U I D E F O R U S E R S N a l t r e x o n e U
A GUIDE FOR USERS UNaltrexone abstinence not using a particular drug; being drug-free. opioid antagonist a drug which blocks the effects of opioid drugs. dependence the drug has become central to a person
More informationOffice-based Treatment of Opioid Dependence with Buprenorphine
Office-based Treatment of Opioid Dependence with Buprenorphine David A. Fiellin, M.D Professor of Medicine, Investigative Medicine and Public Health Yale University School of Medicine Dr. Fiellin s Disclosures
More information2015 OPSC Annual Convention. syllabus. February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California
2015 OPSC Annual Convention syllabus February 4-8, 2015 Hyatt Regency Mission Bay San Diego, California FRIDAY, FEBRUARY 6, 2015: 9:30am - 10:30am Opioid Addiction and Buprenorphine Use * Presented by
More informationThis module reviews the following: Opioid addiction and the brain Descriptions and definitions of opioid agonists,
BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals Module II Opioids 101 Goals for Module II This module reviews the following: Opioid addiction and the brain Descriptions
More informationWe re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones
We re glad you are here! Agenda for the Day Breaks Lunch Q&A and note cards Phones Learn about the history of opioid addiction and discuss what is happening today in Kentucky Learn about the disease of
More informationDeath in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery
Death in the Suburbs: How Prescription Painkillers and Heroin Have Changed Treatment and Recovery Marvin D. Seppala, MD Chief Medical Officer Hazelden Betty Ford Foundation This product is supported by
More informationDEVELOPING MANUFACTURING SUPPLYING. Naltrexone Implants. Manufactured by NalPharm Ltd WWW.NALPHARM.COM
DEVELOPING MANUFACTURING SUPPLYING Naltrexone Implants Background to Nalpharm NalPharm is a specialist pharmaceutical company supplying proprietary branded medications and generic drugs in the area of
More informationTable of Contents. I. Introduction... 2. II. Summary... 3. A. Total Drug Intoxication Deaths... 5. B. Opioid-Related Deaths... 9
Table of Contents I. Introduction... 2 II. Summary... 3 III. Charts A. Total Drug Intoxication Deaths... 5 B. Opioid-Related Deaths... 9 C. Heroin-Related Deaths... 11 D. Prescription Opioid-Related Deaths...
More informationMEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION
MEDICATION ASSISTED TREATMENT FOR OPIOID ADDICTION Mark Fisher Program Administrator State Opioid Treatment Adminstrator Kentucky Division of Behavioral Health OBJECTIVES Learn about types of opioids and
More informationVisit www.takebackmylife.org to hear more of my story or call 211 for help and treatment options
In high school, I experimented with alcohol and pot. Then I moved on to narcotics and cocaine, which landed me in jail several times. By 25, I was a daily heroin user with a long-term prison sentence.
More informationLoved ones or co-workers may notice a number of signs of heroin use, which are visible during and after heroin consumption:
Introduction Heroin is a highly addictive, illegal drug. It is used by millions of addicts around the world who are unable to overcome the urge to continue taking this drug every day of their lives knowing
More informationYoung Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers
Young Adult Prescription Drug Use and Co-Occurring Mental Health Disorders Presenter: Jonathan Beazley, LADC LMFT Moderator: Cindy Rodgers Audio will begin at 2:00 PM ET. You can listen through your computer
More informationOne example: Chapman and Huygens, 1988, British Journal of Addiction
This is a fact in the treatment of alcohol and drug abuse: Patients who do well in treatment do well in any treatment and patients who do badly in treatment do badly in any treatment. One example: Chapman
More informationTreatment of Opioid Dependence: A Randomized Controlled Trial. Karen L. Sees, DO, Kevin L. Delucchi, PhD, Carmen Masson, PhD, Amy
Category: Heroin Title: Methadone Maintenance vs 180-Day psychosocially Enriched Detoxification for Treatment of Opioid Dependence: A Randomized Controlled Trial Authors: Karen L. Sees, DO, Kevin L. Delucchi,
More informationArkansas Emergency Department Opioid Prescribing Guidelines
Arkansas Emergency Department Opioid Prescribing Guidelines 1. One medical provider should provide all opioids to treat a patient s chronic pain. 2. The administration of intravenous and intramuscular
More informationTreatment of opioid use disorders
Treatment of opioid use disorders Gerardo Gonzalez, MD Associate Professor of Psychiatry Director, Division of Addiction Psychiatry Disclosures I have no financial conflicts to disclose I will review evidence
More informationEPIDEMIC 4.6 % OF INDIVIDUALS 18 25 USED PAIN RELIEVERS FOR NON-MEDICAL REASONS. 1.5 MILLION YOUNG ADULTS USED PAIN RELIEVERS IN THE PAST MONTH.
Drug Court EPIDEMIC In the 10 years (1997 2007) the per capita retail purchases of Methadone, Hydrocodone and Oxycodone in the United States increased 13-fold, 4-fold and 9-fold, respectively. 4.6 % OF
More informationHow To Understand The Health Effects Of Prescription Drugs
Miami-Dade, Broward and Palm Beach Counties, Florida Trends of Nonmedical Prescription Drug Misuse in Miami-Dade, Broward, Palm Beach Counties, and the State of Florida: 2010 James N. Hall 1 ABSTRACT The
More informationNeurobiology and Treatment of Opioid Dependence. Nebraska MAT Training September 29, 2011
Neurobiology and Treatment of Opioid Dependence Nebraska MAT Training September 29, 2011 Top 5 primary illegal drugs for persons age 18 29 entering treatment, % 30 25 20 15 10 Heroin or Prescription Opioids
More informationTRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013
2013 to 2002 States: United the in Use Heroin in Trends National Survey on Drug Use and Health Short Report April 23, 2015 TRENDS IN HEROIN USE IN THE UNITED STATES: 2002 TO 2013 AUTHORS Rachel N. Lipari,
More information10/28/2014. Collecting the Raw Opium
Opioid Analgesics (or Narcotic Analgesics) We are moving on to a new category of drugs whose effects, superficially, may look similar to those of the CNS depressants, but the drugs are, in fact, a completely
More informationPrescription drug abuse trends. Minnesota s Prescription Monitoring Program. Minnesota Rural Health Conference June 25, 2013 Duluth
Prescription drug abuse trends Minnesota s Prescription Monitoring Program Carol Falkowski Drug Abuse Dialogues www.drugabusedialogues.com Barbara Carter, Manager MN Board of Pharmacy www.pmp.pharmacy.state.mn.us
More informationFrequently asked questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently asked questions What is Naltrexone? Naltrexone is a prescription drug that completely blocks the effects of all opioid drugs
More informationMedication-Assisted Treatment for Opioid Addiction
Medication-Assisted Treatment for Opioid Addiction This document contains a general discussion of medications approved by the U.S. Food and Drug Administration (FDA) for use in the treatment of opioid
More informationOpiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio
Governor s Cabinet Opiate Action Team Promoting Wellness and Recovery John R. Kasich, Governor Tracy J. Plouck, Director Opiate Addiction in Ohio: An Update on Scope of Problem Ashland Ohio November 14,
More informationCare Management Council submission date: August 2013. Contact Information
Clinical Practice Approval Form Clinical Practice Title: Acute use of Buprenorphine for the Treatment of Opioid Dependence and Detoxification Type of Review: New Clinical Practice Revisions of Existing
More informationOhio Legislative Service Commission
Ohio Legislative Service Commission Bill Analysis Brian D. Malachowsky H.B. 378 130th General Assembly () Reps. Smith and Sprague BILL SUMMARY Prohibits a physician from prescribing or personally furnishing
More informationUsing Buprenorphine in an Opioid Treatment Program
Using Buprenorphine in an Opioid Treatment Program Thomas E. Freese, PhD Director of Training, UCLA Integrated Substance Abuse Programs Director, Pacific Southwest Addiction Technology Transfer Center
More informationNaltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction. Frequently Asked Questions
Naltrexone Pellet Treatment for Opiate, Heroin, and Alcohol Addiction Frequently Asked Questions What is Naltrexone? Naltrexone is a prescription drug that effectively blocks the effects of heroin, alcohol,
More informationOpioid Overdose Prevention Guidelines for Training Responders
Opioid Overdose Prevention Guidelines for Training Responders Oct 31, 2006 OD Oct 31, 2006 Opioid Overdose Prevention Guidelines for Training Responders BACKGROUND Introduction Opioid overdose is a serious
More informationSAFE PAIN MEDICATION PRESCRIBING GUIDELINES
Prescription drug abuse has been declared an epidemic by the Centers for Disease Control. According to 2012 San Diego Medical Examiner data, the number one cause of non-natural death is due to drug overdoses
More informationOVERVIEW OF MEDICATION ASSISTED TREATMENT
Sarah Akerman MD Assistant Professor of Psychiatry Director of Addiction Services Geisel School of Medicine/Dartmouth-Hitchcock Medical Center OVERVIEW OF MEDICATION ASSISTED TREATMENT Conflicts of Interest
More informationAppendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain
Appendix to Tennessee Department of Health: Tennessee Clinical Practice Guidelines for Outpatient Management of Chronic Non- Malignant Pain Division of Workers Compensation 04.01.2015 Background Opioids
More informationDRUGS OF ABUSE CLASSIFICATION AND EFFECTS
Drug and Drug use DRUGS OF ABUSE CLASSIFICATION AND EFFECTS A pharmaceutical preparation or a naturally occurring substance used primarily to bring about a change in the existing process or state (physiological,
More informationIntegrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings
Integrating Medication- Assisted Treatment (MAT) for Opioid Use Disorders into Behavioral and Physical Healthcare Settings All-Ohio Conference 3/27/2015 Christina M. Delos Reyes, MD Medical Consultant,
More informationApplicant Webinar for BJA s Drug Court Discretionary Grant Solicitation
Applicant Webinar for BJA s Drug Court Discretionary Grant Solicitation Cynthia Caporizzo, Senior Criminal Justice Advisor, Office of National Drug Control Policy (ONDCP) - Review of the administration
More informationPrescription Drugs: Abuse and Addiction
EAP Drug Free Workplace Newsletter March 2014 Prescription Drugs: Abuse and Addiction What are some of the commonly abused prescription drugs? Although many prescription drugs can be abused or misused,
More informationTreatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone )
Treatment of Opioid Dependence with Buprenorphine/Naloxone (Suboxone ) Elinore F. McCance-Katz, M.D., Ph.D. Professor and Chair, Addiction Psychiatry Virginia Commonwealth University Neurobiology of Opiate
More informationWhat Parents Need to Know
What Parents Need to Know About Prescription Drug Abuse Office of District Attorney Jonathan W. Blodgett A Message From the District Attorney Prescription drug abuse is a growing problem. According to
More informationJoel Millard, DSW, LCSW Dave Felt, LCSW
Joel Millard, DSW, LCSW Dave Felt, LCSW 1. Provide an overview of the effectiveness of medication assisted treatment, to include a discussion of the different types of medications and how they are used
More informationOVERVIEW WHAT IS POLyDRUG USE? Different examples of polydrug use
Petrol, paint and other Polydrug inhalants use 237 11 Polydrug use Overview What is polydrug use? Reasons for polydrug use What are the harms of polydrug use? How to assess a person who uses several drugs
More informationDrugFacts: Treatment Approaches for Drug Addiction
DrugFacts: Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please
More informationStimulants Notes. What is heroin?
What is heroin? Heroin is an opiate/depressant drug processed from morphine, a naturally occurring substance in the Asian poppy plant. Morphine has been used as a narcotic for thousands of years. According
More informationThe Opiate Epidemic. Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT
The Opiate Epidemic Laura Suminski, MSE, NCC, LPC-IT, SAC-IT Krystle Gutting, MS, LPC-IT, SAC-IT Connections Counseling Madison, WI www.connectionscounseling.com The Opiate Epidemic Opioid-related Facts
More informationUnderstanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders
Understanding Medication Assisted Treatment (MAT) for Families Affected by Substance Use Disorders March 20, 2013 Pamela Petersen- Baston, MPA, CAP, CPP 4 9 4 0 I r v i n e B l v d., S u i t e 2 0 2 I
More informationOpioid Addiction and Methadone: Myths and Misconceptions. Nicole Nakatsu WRHA Practice Development Pharmacist
Opioid Addiction and Methadone: Myths and Misconceptions Nicole Nakatsu WRHA Practice Development Pharmacist Learning Objectives By the end of this presentation you should be able to: Understand how opioids
More informationmethadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment DEPRESSANT Methadone maintenance Pregnancy METHADONE
methadonefact.qxd 8/11/01 2:05 PM Page 1 INFORMATION Advantages of methadone treatment 10 DEPRESSANT Methadone maintenance Pregnancy METHADONE methadonefact.qxd 8/11/01 2:05 PM Page 2 WHAT IS METHADONE
More informationINFO Brief. Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State
ADAI-IB 23-3 INFO Brief Prescription Opioid Use: Pain Management and Drug Abuse In King County and Washington State O ctober 23 Caleb Banta-Green (Alcohol and Drug Abuse Institute, University of Washington),
More informationThis booklet provides information for people who use heroin The National Drug and Alcohol Research Centre (NDARC) has conducted many interviews with
This booklet provides information for people who use heroin The National Drug and Alcohol Research Centre (NDARC) has conducted many interviews with heroin users, many of whom have requested more information
More informationCocaine. Like heroin, cocaine is a drug that is illegal in some areas of the world. Cocaine is a commonly abused drug.
Cocaine Introduction Cocaine is a powerful drug that stimulates the brain. People who use it can form a strong addiction. Addiction is when a drug user can t stop taking a drug, even when he or she wants
More informationPRESCRIPTION DRUG ABUSE prevention
PRESCRIPTION DRUG ABUSE prevention Understanding Drug Addiction Many people do not understand how someone could abuse drugs even when their life seems to be falling apart. It is often assumed that those
More informationBREAKING THE CYCLE. Clermont County s 2015 Response to the Opiate Epidemic
BREAKING THE CYCLE Clermont County s 2015 Response to the Opiate Epidemic SPONSORED BY: Clermont County Mental Health & Recovery Board and Clermont County Public Health Understanding the Opiate Epidemic
More informationTreatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective
Treatment and Interventions for Opioid Addictions: Challenges From the Medical Director s Perspective Dale K. Adair, MD Medical Director/Chief Psychiatric Officer OMHSAS 1 Treatment and Interventions for
More informationTENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION
TENNESSEE BOARD OF MEDICAL EXAMINERS POLICY STATEMENT OFFICE-BASED TREATMENT OF OPIOID ADDICTION The Tennessee Board of Medical Examiners has reviewed the Model Policy Guidelines for Opioid Addiction Treatment
More informationDrug Abuse Trends in Miami-Dade County, Florida: 2009-2010
Drug Abuse Trends in Miami-Dade County, Florida: 2009-2010 James N. Hall 1 ABSTRACT Cocaine consequences as a proportion of all drug problems continue to be higher in South Florida than in most of the
More informationDosing Guide. For Optimal Management of Opioid Dependence
Dosing Guide For Optimal Management of Opioid Dependence KEY POINTS The goal of induction is to safely suppress opioid withdrawal as rapidly as possible with adequate doses of Suboxone (buprenorphine HCl/naloxone
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE September 4, 2015 SUBJECT EFFECTIVE DATE September 9, 2015 MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments, Oral Buprenorphine Agents - Pharmacy
More informationTreatment Approaches for Drug Addiction
Treatment Approaches for Drug Addiction NOTE: This is a fact sheet covering research findings on effective treatment approaches for drug abuse and addiction. If you are seeking treatment, please call the
More informationIN THE GENERAL ASSEMBLY STATE OF. Ensuring Access to Medication Assisted Treatment Act
IN THE GENERAL ASSEMBLY STATE OF Ensuring Access to Medication Assisted Treatment Act 1 Be it enacted by the People of the State of Assembly:, represented in the General 1 1 1 1 Section 1. Title. This
More informationTufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management
Tufts Health Care Institute Program on Opioid Risk Management Pharmacotherapy for Prescription Opioid Addiction: Implications for Pain Management June 10 and 11, 2011 Executive Summary Introduction Opioid
More informationNew York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery
New York State Office of Alcoholism & Substance Abuse Services Addiction Services for Prevention, Treatment, Recovery USING THE 48 HOUR OBSERVATION BED USING THE 48 HOUR OBSERVATION BED Detoxification
More informationMedications for Alcohol and Drug Dependence Treatment
Medications for Alcohol and Drug Dependence Treatment Robert P. Schwartz, M.D. Medical Director Rschwartz@friendsresearch.org Friends Research Institute Medications for Alcohol Dependence Treatment Disulfiram
More informationIntake Consultation and Assessment Before Detox. What Happens During Drug Detox?
What Happens During Drug Detox? Many addicts and alcoholics believe they can quit using substances on their own. But after a few painful and confidence-crushing failed attempts, the need for an inpatient
More informationHow To Treat A Drug Addiction
1 About drugs Drugs are substances that change a person s physical or mental state. The vast majority of drugs are used to treat medical conditions, both physical and mental. Some, however, are used outside
More informationPARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications
PARTNERSHIP HEALTHPLAN RECOMMENDATIONS For Safe Use of Opioid Medications Primary Care & Specialist Prescribing Guidelines Introduction Partnership HealthPlan is a County Organized Health System covering
More informationMEDICAL ASSISTANCE BULLETIN
ISSUE DATE SUBJECT EFFECTIVE DATE MEDICAL ASSISTANCE BULLETIN NUMBER *See below BY Prior Authorization of Opiate Dependence Treatments Pharmacy Service Leesa M. Allen, Deputy Secretary Office of Medical
More informationSubstitution Therapy for Opioid Dependence The Role of Suboxone. Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015
Substitution Therapy for Opioid Dependence The Role of Suboxone Mandy Manak, MD, ABAM, CCSAM Methadone 101-Hospitalist Workshop, October 3, 2015 Objectives Recognize the options available in treating opioid
More informationBenzodiazepines. And Sleeping Pills. Psychological Medicine
Benzodiazepines And Sleeping Pills Psychological Medicine Introduction Benzodiazepines are a type of medication prescribed by doctors for its therapeutic actions in various conditions such as stress and
More informationSUBOXONE /VIVITROL WEBINAR. Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12
SUBOXONE /VIVITROL WEBINAR Educational Training tool concerning the Non-Methadone Medication Assisted Treatment Policy that is Effective on 1/1/12 WEBINAR INTRODUCTIONS Cynthia Parsons- Program Manager
More information